Vitabolik Pharmaceuticals

Metabolic Disorders today is slowly becoming an epidemic and India today is poised to becoming the Metabolic Disorder Capital of the World. Blood Pressure, Cholesterol & Diabetes are the three major Silent Killers affecting other major organ damage. Lack of awareness, diagnosis and proper healthcare management systems increases the risk of morbidity and mortality. SKM Group, already having recognizable presence in healthcare industry in eastern India, now ventures into the pharmaceutical industry with VITABOLIK PHARMACEUTICALS PVT LTD, focusing on the above disease and therapies. With the vision of becoming a trusted and admirable partner to the society in treating metabolic disorders, VBPPL offers therapies for blood pressure, cholesterol, heart failure, diabetes, nerve disorders and sexual dysfunction.